Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Howard G Birnbaum

Showing results (21-30 of 112) with videos related to

Pageof 12
Sort By:
Pharmacoeconomics|April 21, 2010
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the USCrystal Pike, Howard G Birnbaum, Matt Schiller, et al.
Journal of Medical Economics|July 23, 2014
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladderJasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, et al.
Pharmacoeconomics|July 14, 2010
Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their familiesAndrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 14, 2013
An economic model of Parkinson's disease: implications for slowing progression in the United StatesScott J Johnson, Melissa D Diener, Anna Kaltenboeck, et al.
Drugs & Aging|December 23, 2010
Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care planJasmina I Ivanova, Catherine Bienfait-Beuzon, Howard G Birnbaum, et al.
Pharmacoeconomics|August 29, 2009
The cost of disability and medically related absenteeism among employees with multiple sclerosis in the USJasmina I Ivanova, Howard G Birnbaum, Seth Samuels, et al.
Applied Health Economics and Health Policy|September 6, 2011
Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured populationNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
Applied Health Economics and Health Policy|August 31, 2011
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured populationNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 16, 2005
Incidence and costs of accidents among attention-deficit/hyperactivity disorder patientsAndrine Swensen, Howard G Birnbaum, Rym Ben Hamadi, et al.
Pageof 12

Showing results (21-30 of 112) with videos related to

Sort By:
Pageof 12
Pharmacoeconomics|April 21, 2010
Direct and indirect costs of non-vertebral fracture patients with osteoporosis in the USCrystal Pike, Howard G Birnbaum, Matt Schiller, et al.
Journal of Medical Economics|July 23, 2014
Healthcare resource use and costs of privately insured patients who switch, discontinue, or persist on anti-muscarinic therapy for overactive bladderJasmina I Ivanova, Eleanor Hayes-Larson, Rachael A Sorg, et al.
Pharmacoeconomics|July 14, 2010
Economic burden of epilepsy among the privately insured in the USJasmina I Ivanova, Howard G Birnbaum, Yohanne Kidolezi, et al.
Journal of the American Academy of Child and Adolescent Psychiatry|November 25, 2003
Attention-deficit/hyperactivity disorder: increased costs for patients and their familiesAndrine R Swensen, Howard G Birnbaum, Kristina Secnik, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 14, 2013
An economic model of Parkinson's disease: implications for slowing progression in the United StatesScott J Johnson, Melissa D Diener, Anna Kaltenboeck, et al.
Drugs & Aging|December 23, 2010
Physicians' decisions to prescribe antidepressant therapy in older patients with depression in a US managed care planJasmina I Ivanova, Catherine Bienfait-Beuzon, Howard G Birnbaum, et al.
Pharmacoeconomics|August 29, 2009
The cost of disability and medically related absenteeism among employees with multiple sclerosis in the USJasmina I Ivanova, Howard G Birnbaum, Seth Samuels, et al.
Applied Health Economics and Health Policy|September 6, 2011
Excess costs associated with patients with chronic thromboembolic pulmonary hypertension in a US privately insured populationNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
Applied Health Economics and Health Policy|August 31, 2011
Excess costs associated with patients with pulmonary arterial hypertension in a US privately insured populationNoam Y Kirson, Howard G Birnbaum, Jasmina I Ivanova, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|April 16, 2005
Incidence and costs of accidents among attention-deficit/hyperactivity disorder patientsAndrine Swensen, Howard G Birnbaum, Rym Ben Hamadi, et al.
Pageof 12